Andrew Tsourkas, Ph.D. is a Professor and Undergraduate Chair of Bioengineering at the University of Pennsylvania. He received his Bachelor’s degree in Mechanical Engineering in 1997 from Cornell University and his Ph.D. in Biomedical Engineering from the Georgia Tech/Emory University joint Ph.D. program in 2002. He conducted a post-doctoral fellowship in the Department of Radiology at Harvard University, before joining the Department of Bioengineering at the University of Pennsylvania in 2004. Dr. Tsourkas is currently the Co-Director for the Center for Targeted Therapeutics and Translational Nanomedicine as well as the Chemical and Nanoparticle Synthesis Core. He was a recipient of the Coulter Foundation Early Career Award, the National Science Foundation CAREER Award, and was elected fellow of the American Institute for Medical and Biological Engineering. Dr. Tsourkas founded AlphaThera, Inc. in 2016, a biotechnology company that develops reagents for the site-specific labeling of antibodies.